A meta-analysis of hormone replacement therapy and colon cancer in women

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 8, 1998, Pages 653-659

  Hébert Croteau, Nicole ^a  

^a Gouvernement du Quebec   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ARTICLE; CANCER RISK; COLON CANCER; DISEASE ASSOCIATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; META ANALYSIS; PRIORITY JOURNAL; RISK MANAGEMENT;

ADULT; AGE DISTRIBUTION; AGED; CANADA; CASE-CONTROL STUDIES; COHORT STUDIES; COLONIC NEOPLASMS; CONFIDENCE INTERVALS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 0031830247     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. McMichael, A. J , and Potter, J D. Reproduction, endogenous and exogenous sex hormones, and colon Cancer, a review and hypothesis. J. Natl. Cancer Inst., 65: 1201-1207, 1980.
2. Potter, J. D., Slattery, M. L., Bostick, R. M., and Gapstur, S. M. Colon Cancer a review of the epidemiology. Epidemiol. Rev., 15: 499-545, 1993.
3. Potter, J D Hormones and colon Cancer. J. Natl. Cancer Inst, 87. 1039-1040, 1995.
4. Bush, T. L., and Barrett-Connor, E. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol. Rev , 7: 80-104, 1985
5. Hemminki, E., Kennedy, D. L., Baum, C., and McKinley, S. M. Prescribing of noncontraccptive estrogens and progestins in the United States, 1974-86. Am. J Public Health, 78: 1479-1481, 1988
6. Derby, C. A., Lamont Hume, A., McFarland Barbour, M., McPhillips, J. B., Lasater, T. M., and Carleton, R. A. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am. J. Epidemiol, 137. 1125-1135, 1993.
7. Johannes, C. B , Crawford, S. L , Posner, J G , and McKinlay, S. M. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women Am. J. Epidemiol., 140. 439-452, 1994.
8. Potter, J. D., Bostick, R. M , Grandiis, G. A., Fosdick, L , Elmer, P , Wood, J , Grambsch, P , and Louis, T. A. Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer prevention research unit case-control study. Cancer Epidemiol. Biomark. Prev., 5: 779-784, 1996
9. MacLennan, S. C., MacLennan, A. H., and Ryan, P. Colorectal Cancer and oestrogen replacement therapy A meta-analysis of epidemiologic studies. Med. J. Aust., 162. 491-493, 1995.
10. Rutqvist, L. E , Johansson, H., Signomklao, T., Johansson, U., Fornander, T., and Wilking, N. for the Stockholm Breast Cancer Study Group. Adjuvant tamoxifen therapy for early stage breast Cancer and second primary malignancies. J Natl Cancer Inst, 87. 645-651, 1995.
11. Powles, T. J , and Hickish, T. Tamoxifen therapy and carcinogenic risk. J Natl. Cancer Inst., 87. 1343-1344, 1995
12. Prentice, R., Rossouw, J. R., Johnson, S. R., Freedman, L. S., and McTieman, A. The role of randomized controlled trial in assessing the benefits and risks of long-term hormone replacement therapy: example of the Women's Health Initiative. Menopause, 3: 71-76, 1996.
13. Greenland, S. Invited commentary: a critical look at some popular epidemiologic methods Am J Epidemiol , 140: 290-296, 1994.
14. Greenland, S Can meta-analysis be salvaged? Am J. Epidemiol., 140: 783-787, 1994.
15. Rosenberg, L , Werler, M M., Kaufman, D. W., and Shapiro, S. Cancers of the colon and rectum in relation to reproductive factors. Am. J. Epidemiol., 126: 760-761, 1987.
16. Newcomb, P A., Storer, B. E., and Marcus, P. M Cancer of the large bowel in relation to use of hormone replacement therapy Am. J Epidemiol, 136. 958, 1992
17. Newcomb, P A., and Storer, B E Postmenopausal hormone use and risk of large-bowel Cancer. J. Natl. Cancer Inst., 87: 1067-1071, 1995.
18. Grodstein, F., Martinez, M. E., Giovannucci, E. L., Colditz, G. A , Hunter, D. J , Willett, W. C., Speizer, F. E., and Stampfer, M. J. Postmenopausal hormone use and colorectal Cancer in the Nurses' Health Study. Am. J Epidemiol., 11: S63, 1996.
19. Chute, C. G., Willett, W. C., Colditz, G A , Stampfer, M. J., Rosner, B., and Speizer, F. E. A prospective study of reproductive history and exogenous estrogens on the risk of colorectal Cancer in women Epidemiology, 2: 201-207, 1991.
20. Bostick, R. M , Potter, J D , Kushi, L H., Sellers, T A., Steinmetz, K A., McKenzic, D R., Gapstur, S M., and Folsom, A. R Sugar, meat, and fat intake, and non-dietary risk factors for colon Cancer incidence in Iowa women (United States) Cancer Causes Control, 5. 38-52, 1994.
21. Folsom, A. R., Mink, P. J., Sellers, T. A , Hong, C-P., Zheng, W , and Potter, J. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am. J. Public Health, 85: 1128-1132, 1995.
22. Wu-Williams, A H , Lee, M , Whittemore, A. S., Gallagher, R. P., Deng-ao, J., Shu, Z, Lun, Z., Xianghui, W , Kun, C., Jung, D , Teh, C., Chengde, L., Yao, X J., Paffenbarger, R. S., and Henderson, B. E. Reproductive factors and colorectal Cancer risk among Chinese females Cancer Res, 51. 2307-2311, 1991.
23. Woolf, B. On estimating the relation between blood group and disease. Ann Hum Genet., 19: 251-253, 1955.
24. Greenland, S. Quantitative methods in the review of epidemiologic literature. Epidemiol. Rev., 9: 1-30, 1987
25. DerSimonian, R , and Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials, 7. 177-188, 1986.
26. Colditz, G. A , Burdick, E., and Mosteller, F Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. Am J. Epidemiol, 142: 371-382, 1995.
27. Nachtigall, L. E , Nachtigall, R. H., Nachtigall, R. D., and Beckman, M. Estrogen replacement therapy. II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol, 54. 74-79, 1979.
28. Hammond, C. B., Jelovsek, F. R., Lee, K.I., Creasman, W. T., and Parker, R T. Effects of long-term estrogen replacement therapy II. Neoplasia. Am. J. Obstet Gynecol, 133: 537-547, 1979.
29. Davis, F. G., Furner, S E , Persky, V., and Koch, M. The influence of parity and exogenous female hormones on the risk of colorectal Cancer Int. J Cancer, 43: 587-590, 1989.
30. Wu, A H, Paganini-Hill, A , Ross, R K., and Henderson, B E Alcohol, physical activity and other risk factors for colorectal Cancer: a prospective study Br. J. Cancer, 55: 687-694, 1987.
31. Adami, H-O., Persson, I , Hoover, R., Schairer, C , and Bergkvist, L. Risk of Cancer in women receiving hormone replacement therapy. Int. J Cancer, 44. 833-839, 1989.
32. Weiss, N. S., Daling, J. R., and Chow, W. H. Incidence of Cancer of the large bowel in women in relation to reproductive and hormonal factors. J. Natl. Cancer Inst., 67: 57-60, 1981
33. Potter, J. D., and McMichael, A. J. Large bowel Cancer in women in relation to reproductive and hormonal factors: a case-control study. J. Natl. Cancer Inst., 71: 703-709, 1983.
34. Fumer, S. E., Davis, F. G., Nelson, R. L , and Haenszel, W. A case-control study of large bowel Cancer and hormone exposure in women Cancer Res , 49 4936-4940, 1989.
35. Burch, J. C., Byrd, B. F., and Vaughn, W. K. The effects of long-term estrogen administration to women following hysterectomy Front Horm. Res. (Basel), 3: 208-214, 1975.
36. Calle, E. E., Miracle-McMahill, H. L., Thun, M. J., and Heath, C. W. Estrogen replacement therapy and risk of fatal colon Cancer in a prospective cohort of postmenopausal women J. Natl Cancer Inst, 87. 517-523, 1995.
37. Risch, H. A., and Howe, G. R. Menopausal hormone use and colorectal Cancer in Saskatchewan: a record linkage cohort study. Cancer Epidemiol Biomark. Prev., 4. 21-28, 1995
38. Peters, R K., Pike, M. C., Chang, W. W. L , and Mack, T. M. Reproductive factors and colon Cancers Br. J. Cancer. 61. 741-748, 1990
39. Gerhardsson de Verdier, M , and London, S Reproductive factors, exogenous female hormones, and colorectal Cancer by subsite. Cancer Causes Control, 3: 355-360, 1992
40. Jacobs, E. J., White, E., and Weiss, N S. Exogenous hormones, reproductive history, and colon Cancer (Seattle, Washington, USA) Cancer Causes Control, 5: 359-366, 1994.
41. Fernandez, E., La Vecchia, C., D'Avanzo, B , Franceschi, S., Negri, E., and Parazzini, F Oral contraceptives, hormone replacement therapy and the risk of colorectal Cancer. Br. J. Cancer, 73: 1431-1435, 1996.
42. Greenland, S., and Longnecker, M. P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am. J. Epidermol, 135: 1301-1309, 1992.
43. Rothman, K J. Analysis of crude data. In: Modem Epidemiology, pp 153-176. Boston: Little, Brown, and Co., 1986.
44. Friedenreich, C. M. Methods for pooled analyses of epidemiologic studies. Epidemiology, 4 295-302, 1993.
45. Persson, I., Bergkvist, L., and Adami, H-O. Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms. Int. J. Epidemiol., 16: 222-228, 1987
46. Harlow, S D., and Linet, M S. Agreement between questionnaire data and medical records. Am. J. Epidemiol, 129: 233-248, 1989
47. Goodman, M. T., Nomura, A. M. Y., Wilkens, L. R., and Kolonel, L. N. Agreement between interview information and physician records on history of menopausal estrogen use. Am J. Epidemiol, 131 815-825, 1990
48. West, S. L , Savitz, D. A , Koch, G., Strom, B. L., Guess, H A., and Hartzema, A. Recall accuracy for prescription medications: self-report compared with database information. Am. J. Epidemiol., 142: 1103-1112, 1995
49. Lancaster, T., Surman, G., Lawrence, M., Mant, D., Vessey, M., Thorogood, M , Yudkin, P., and Daly, E Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records J. Epidemiol Community Health, 49: 389-394, 1995.
50. Sturgeon, S. R., Schairer, C., Brinton, L A., Pearson, T., and Hoover, R N. Evidence of a healthy estrogen user survivor effect. Epidemiology, 6. 227-231, 1995
51. Dickersm, K. The existence of publication bias and risk factors for its occurrence. J Am. Med. Assoc., 263: 1385-1389, 1990
52. LeLorier, J , Grégoire, G., Benhaddad, A., Lapierre, J , and Derderian, F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N. Engl J. Med., 337: 536-542, 1997.
53. Shapiro, S. Is meta-analysis a valid approach to the evaluation of small effects in observational studies? J. Clin. Epidemiol , 50: 223-229, 1997.
54. Thompson, S. G., and Pocock, S. J. Can meta-analyses be trusted? Lancet, 338. 1127-1130, 1991.
55. Dickersin, K , and Berlin, J. A Meta-analysis: state-of-the-science. Epidemiol Rev , 14. 154-176, 1992.
56. Santé Québec Bellerose, C , Lavallée, C., Chénard, L., et Levasseur, M. (sous la direction de). Et la santé, ça va en 1992-1993? Rapport de l'enquête sociale et de santé 1992-1993, volume I. Ministère de la santé et des services sociaux. Gouvernement du Québec, Montréal, 1995
57. Santé Québec Et la santé, ça va? Rapport de l'enquête Santé Québec 1987, Tome I. Ministère de la santé et des services sociaux, Gouvernement du Québec, Montréal, 1988.
58. Brinton, L. A., and Schairer, C Estrogen replacement therapy and breast Cancer risk Epidemiol. Rev., 15: 66-79, 1993.
59. Grodstein, F , Stampfer, M J , Colditz, G. A , Willen, W. C , Manson, J. E., Joffe, M., Rosner, B., Fuchs, C., Hankinson, S E , Hunter, D. J , Hennekens, C. H., and Speizer, F E. Postmenopausal hormone therapy and mortality N Engl J. Med., 336. 1769-1775, 1997.